DSM-5-TR: The Standard for Psychiatric Diagnosis
The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) is the authoritative guide for diagnosing mental health conditions. Published in 2022, it reflects the latest clinical evidence and diagnostic criteria used by healthcare professionals worldwide.
Overview of DSM-5-TR
Unlike major revisions (DSM-IV to DSM-5), a text revision updates language, clarifies criteria, and incorporates new evidence without fundamentally restructuring the classification system. The TR adds Prolonged Grief Disorder and refines cultural formulation across all 297 disorders.
Key Features
Updated Diagnostic Criteria
Over 70 text revisions based on literature review
Cultural Considerations
Enhanced cultural concepts and diversity
New Disorders
Prolonged Grief Disorder, Unspecified Mood Disorder
ICD-11 Alignment
Better coordination with WHO coding system
Structure & Organization
The DSM-5-TR maintains the lifespan organization introduced in DSM-5, moving away from the multiaxial system of DSM-IV. Disorders are grouped into 20 diagnostic classes organized by developmental trajectory and symptom similarity.
| Diagnostic Category | Disorder Count | Key Examples |
|---|---|---|
| Neurodevelopmental Disorders | 32 | ADHD, Autism Spectrum, Intellectual Disability, Specific Learning Disorder, Communication Disorders, Motor Disorders (Tics, Tourette's) |
| Schizophrenia Spectrum & Other Psychotic Disorders | 10 | Schizophrenia, Schizoaffective Disorder, Delusional Disorder, Brief Psychotic Disorder, Schizophreniform Disorder |
| Bipolar & Related Disorders | 8 | Bipolar I, Bipolar II, Cyclothymic Disorder, Substance-Induced Bipolar Disorder |
| Depressive Disorders | 10 | Major Depressive Disorder, Persistent Depressive Disorder (Dysthymia), Premenstrual Dysphoric Disorder, Disruptive Mood Dysregulation Disorder |
| Anxiety Disorders | 12 | Generalized Anxiety Disorder, Panic Disorder, Social Anxiety Disorder, Specific Phobia, Separation Anxiety, Selective Mutism |
| Obsessive-Compulsive & Related Disorders | 10 | OCD, Body Dysmorphic Disorder, Hoarding Disorder, Trichotillomania, Excoriation (Skin-Picking) Disorder |
| Trauma- & Stressor-Related Disorders | 9 | PTSD, Complex PTSD, Acute Stress Disorder, Adjustment Disorders, Reactive Attachment Disorder, Disinhibited Social Engagement Disorder, Prolonged Grief Disorder (NEW in TR) |
| Dissociative Disorders | 5 | Dissociative Identity Disorder, Dissociative Amnesia, Depersonalization/Derealization Disorder |
| Somatic Symptom & Related Disorders | 7 | Somatic Symptom Disorder, Illness Anxiety Disorder, Conversion Disorder, Factitious Disorder |
| Feeding & Eating Disorders | 8 | Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder, Avoidant/Restrictive Food Intake Disorder (ARFID), Pica, Rumination Disorder |
| Elimination Disorders | 2 | Enuresis (bed-wetting), Encopresis |
| Sleep-Wake Disorders | 13 | Insomnia Disorder, Hypersomnolence Disorder, Narcolepsy, Sleep Apnea, Restless Legs Syndrome, Nightmare Disorder, Non-REM Sleep Arousal Disorders |
| Sexual Dysfunctions | 10 | Erectile Disorder, Female Sexual Interest/Arousal Disorder, Premature Ejaculation, Delayed Ejaculation, Female Orgasmic Disorder, Genito-Pelvic Pain/Penetration Disorder |
| Gender Dysphoria | 2 | Gender Dysphoria in Children, Gender Dysphoria in Adolescents/Adults |
| Disruptive, Impulse-Control & Conduct Disorders | 9 | Oppositional Defiant Disorder, Intermittent Explosive Disorder, Conduct Disorder, Antisocial Personality Disorder, Pyromania, Kleptomania |
| Substance-Related & Addictive Disorders | 103 | Alcohol, Opioid, Cannabis, Stimulant, Hallucinogen, Sedative Use Disorders + Gambling Disorder (only behavioral addiction in DSM-5-TR) |
| Neurocognitive Disorders | 14 | Major/Mild Neurocognitive Disorder due to Alzheimer's, Vascular Disease, Traumatic Brain Injury, Lewy Body Disease, Frontotemporal Lobar Degeneration, HIV, Prion Disease |
| Personality Disorders | 10 | Paranoid, Schizoid, Schizotypal, Antisocial, Borderline, Histrionic, Narcissistic, Avoidant, Dependent, Obsessive-Compulsive Personality Disorders |
| Paraphilic Disorders | 9 | Voyeuristic, Exhibitionistic, Frotteuristic, Sexual Masochism, Sexual Sadism, Pedophilic, Fetishistic, Transvestic Disorder |
| Other Mental Disorders & Medication-Induced | 15 | Other Specified/Unspecified Mental Disorder, Medication-Induced Movement Disorders, Other Adverse Effects of Medication |
| TOTAL DISORDERS IN DSM-5-TR | 297 | Across 20 major diagnostic classes |
Note on Disorder Counts: Substance-Related Disorders account for 103 disorders (10 substance classes × ~10 diagnoses each: use disorder, intoxication, withdrawal, etc.). The remaining 194 disorders span the other 19 diagnostic categories.
Clinical Application: How to Use the DSM-5-TR
The DSM-5-TR is not merely a reference book, it's a clinical tool designed to standardize diagnosis across settings. Understanding how to properly apply diagnostic criteria is essential for accurate assessment.
Step-by-Step Diagnostic Process
Clinical Interview & Observation
Gather presenting symptoms, duration, severity, and functional impairment through structured or semi-structured clinical interview.
Rule Out Medical Causes
Exclude substance-induced symptoms, medication side effects, and general medical conditions that better explain the presentation.
Match to Diagnostic Criteria
Systematically review criteria for candidate disorders. Count symptoms meeting threshold (e.g., "5 of 9" for Major Depression). Verify duration requirements.
Assess Functional Impairment
Criterion B in most disorders requires "clinically significant distress or impairment in social, occupational, or other important areas of functioning."
Differential Diagnosis
Consider alternative diagnoses that could explain symptoms. Review "Differential Diagnosis" section in DSM for each candidate disorder.
Specify Severity & Subtypes
Add severity specifiers (Mild, Moderate, Severe), course specifiers (In Remission, Recurrent), and subtypes where applicable.
Document Comorbidities
List all co-occurring disorders. DSM-5-TR removed diagnostic hierarchy, patients can have multiple diagnoses simultaneously.
Critical Clinical Judgment Points
- Cultural Context: Symptoms must be understood within patient's cultural framework. What appears as delusion in one culture may be normative spiritual belief in another.
- Developmental Stage: Diagnostic thresholds differ across lifespan. ADHD hyperactivity normal in toddlers, pathological in adults.
- Functional Impairment: Subclinical symptoms without impairment don't warrant diagnosis. Diagnosis requires interference with daily functioning.
Severity Specifiers & Dimensional Assessment
DSM-5-TR moves beyond binary diagnosis toward dimensional assessment, recognizing that mental disorders exist on a continuum. Severity specifiers provide clinically meaningful gradations.
Common Severity Levels
Mild
Few symptoms beyond minimum required; minor functional impairment
Moderate
Symptoms/functional impairment between "mild" and "severe"
Elevated
Many symptoms beyond minimum; marked functional impairment or risk to self/others
Course Specifiers
In Partial Remission
Previously met full criteria; now some symptoms remain but full criteria not met
In Full Remission
No longer meets criteria for specific time period (typically 2-12 months)
Recurrent
Two or more episodes with period of remission between episodes
Disorder-Specific Examples
Major Depressive Disorder
Specify: Severity (Mild/Moderate/Severe), With anxious distress, With mixed features, With melancholic features, With atypical features, With mood-congruent psychotic features, With mood-incongruent psychotic features, With catatonia, With peripartum onset, With seasonal pattern
Autism Spectrum Disorder
Specify: Level 1 (Requiring support), Level 2 (Requiring substantial support), Level 3 (Requiring very substantial support); With or without accompanying intellectual impairment; With or without accompanying language impairment; Associated with known genetic or medical condition
Substance Use Disorder
Specify: Mild (2-3 symptoms), Moderate (4-5 symptoms), Severe (6+ symptoms); In early remission (3-12 months), In sustained remission (12+ months); In a controlled environment (e.g., incarceration)
Evolution of the DSM
DSM-I
1952First edition with 106 mental disorders. Focused on psychoanalytic concepts and reactions to psychological, social, and biological factors.
DSM-II
1968Expanded to 182 disorders. Began shift toward descriptive terminology. Removed term "reaction" from many diagnoses.
DSM-III
1980LandmarkRevolutionary change: Introduced multiaxial system and specific diagnostic criteria. Embraced descriptive, atheoretical approach. 265 disorders.
DSM-III-R
1987Text revision refining diagnostic criteria based on clinical feedback. 292 disorders.
DSM-IV
1994Evidence-based revision with extensive literature review. Added cultural considerations and decision trees. 297 disorders.
DSM-IV-TR
2000Text revision updating associated features, prevalence data, and ICD codes. Same diagnostic criteria as DSM-IV.
DSM-5-TR
2013Major revision: Removed multiaxial system. Added dimensional assessments. Reorganized by lifespan. 297 disorders with restructured categories.
DSM-5-TR
20222022 • CurrentLatest edition: Text revision with 70+ updates. Added Prolonged Grief Disorder. Enhanced cultural content. Updated terminology for inclusivity.
What's Next? The APA has not announced DSM-6. Future revisions will likely incorporate biomarkers, dimensional assessment, and digital phenotyping as discussed in the "Future of the DSM" section below.
Key Changes from DSM-5 to DSM-5-TR
Prolonged Grief Disorder
New diagnosis for persistent, intense grief lasting 12+ months (6+ months for children) after loss of a loved one. Distinguishes pathological grief from normal bereavement.
Revised Terminology
Updated language to reduce stigma and improve cultural sensitivity:
- "Intellectual Disability" replaces outdated terms
- "Substance Use Disorder" emphasizes medical model
- Gender-inclusive language throughout diagnostic criteria
- Person-first language ("person with schizophrenia" vs "schizophrenic")
Suicidal Behavior & Nonsuicidal Self-Injury Codes
DSM-5-TR added new ICD-10-CM billing codes for suicidal behavior and nonsuicidal self-injury to Section II under "Other Conditions That May Be a Focus of Clinical Attention." Suicidal Behavior Disorder (SBD) itself remains in Section III ("Conditions for Further Study") - it was not elevated to a full diagnosis. These codes allow clinicians to document suicidal episodes independently of any specific diagnostic category, improving clinical granularity and billing accuracy.
Updated Symptom Criteria
Autism Spectrum Disorder
Clarified sensory sensitivity criteria and expanded cultural considerations for diagnosis across diverse populations
PTSD
Updated Criterion A (trauma exposure) with more precise language about indirect/media exposure limitations
Major Depression
Clarified bereavement exclusion removal rationale and cultural considerations for depressive symptoms
Social Anxiety:
Expanded description of cultural variations in social anxiety presentation across ethnic groups
Common Comorbidity Patterns
Psychiatric comorbidity, the co-occurrence of two or more disorders, is the rule rather than the exception. Understanding common comorbidity patterns improves diagnostic accuracy and treatment planning.
Depression + Anxiety
Prevalence: 60% of patients with Major Depression have comorbid anxiety disorder [Kessler et al., 2005]
Clinical Note: Shared symptoms (sleep disturbance, concentration difficulty, fatigue) require careful assessment. Consider "With anxious distress" specifier for MDD rather than separate GAD diagnosis if anxiety is exclusively worry about depressive symptoms.
ADHD + Learning Disorders
Prevalence: 25–45% of children with ADHD have comorbid Specific Learning Disorder [DuPaul et al., 2013]
Clinical Note: Distinguishing inattention due to ADHD from learning disability-related frustration requires neuropsychological testing and academic history review.
PTSD + Substance Use
Prevalence: 40–50% of individuals with PTSD develop substance use disorder [Brady & Sinha, 2005]
Clinical Note: Self-medication hypothesis suggests trauma survivors use substances to manage intrusive symptoms. Integrated treatment addressing both disorders simultaneously shows better outcomes than sequential treatment.
Bipolar + Substance Use
Prevalence: ~56% lifetime prevalence of substance use disorder in Bipolar I Disorder [Regier et al., 1990, ECA]
Clinical Note: Substance-induced mood episodes can mimic bipolar disorder. Longitudinal history showing mood episodes independent of substance use required for bipolar diagnosis.
Autism + ADHD
Prevalence: 50–70% of individuals with Autism Spectrum Disorder meet criteria for ADHD [Leitner, 2014]
Clinical Note: DSM-5 removed the exclusion criterion preventing concurrent ADHD and Autism diagnosis. Both can now be diagnosed if full criteria met for each.
Eating Disorders + Mood/Anxiety
Prevalence: 94%+ of individuals with eating disorders have at least one comorbid DSM disorder [Hudson et al., 2007]
Clinical Note: Depression and anxiety may be secondary to malnutrition (starvation causes mood symptoms). Reassess after nutritional rehabilitation to determine which symptoms persist.
Clinical Implication: High comorbidity rates suggest shared neurobiological mechanisms. The Research Domain Criteria (RDoC) framework proposed by NIMH organizes psychopathology by underlying constructs (negative valence systems, cognitive systems) rather than categorical diagnoses, better capturing comorbid presentations.
Cultural Formulation & Diversity Considerations
DSM-5-TR expanded cultural content by 40%, recognizing that culture profoundly shapes symptom expression, help-seeking behavior, and treatment response. The Cultural Formulation Interview (CFI) provides a framework for systematic cultural assessment.
Cultural Formulation Interview (CFI)
The CFI is a 16-question semi-structured interview addressing four domains:
1. Cultural Definition of the Problem
How does the individual understand their problem? What name does their culture give it? What cultural idioms of distress do they use?
2. Cultural Perceptions of Cause
What caused the problem from cultural perspective? Spiritual factors? Family dynamics? Stress? Evil eye? Karma?
3. Cultural Factors Affecting Help-Seeking
What types of support are culturally expected? Barriers to seeking professional help? Stigma concerns? Preference for traditional healers?
4. Cultural Factors Affecting Treatment
Cultural views on medication? Therapy? What treatment approaches are culturally acceptable? Role of family in treatment decisions?
Cultural Concepts of Distress
DSM-5-TR retains 9 named Cultural Concepts of Distress in the Glossary (reduced from 25 in DSM-IV-TR, with greater focus on clinical utility). Examples:
Ataque de nervios (Latin American cultures)
Intense emotional distress with crying, trembling, heat in chest rising to head, shouting, aggression, suicidal gestures. Triggered by stressful family events. May meet criteria for Panic Disorder but requires cultural context.
Taijin kyofusho (Japan, Korea)
Fear of offending others through one's appearance, body odor, facial expressions, or eye contact. Related to Social Anxiety Disorder but distinct cultural focus on causing discomfort to others rather than self-embarrassment.
Khyâl cap (Cambodian)
"Wind overload" - bodily wind rising in the body causing dizziness, tinnitus, neck soreness. Associated with panic attacks but requires understanding of Cambodian ethnomedical system.
Mal de ojo (Mediterranean, Latino)
"Evil eye" - belief that intense admiration or envy can cause illness, especially in children. May present with anxiety, insomnia, crying. Requires cultural explanation; not delusional disorder in cultural context.
Dhat syndrome (South Asian cultures)
Anxiety and hypochondriacal concerns about semen loss through nocturnal emission, masturbation, or urination. May present as depressive/anxiety symptoms requiring cultural understanding of traditional medicine concepts.
Clinical Guidance: When evaluating patients from different cultural backgrounds, avoid "category fallacy",imposing Western diagnostic categories on non-Western presentations. Use CFI to understand symptom meaning within patient's cultural framework before assigning DSM diagnosis.
ICD-10-CM & ICD-11 Crosswalk
ICD-11-CM F codes — required for US insurance billing
While DSM-5-TR guides clinical diagnosis, billing and international classification use ICD codes. Understanding the relationship between DSM and ICD is essential for clinical documentation and epidemiological research.
Key Coding Examples
| DSM-5-TR Diagnosis | ICD-10-CM Code | ICD-11 Code |
|---|---|---|
| Major Depressive Disorder, Single Episode, Moderate | F32.1 | 6A70.1 |
| Generalized Anxiety Disorder | F41.1 | 6B00 |
| PTSD | F43.10 | 6B40 |
| Alcohol Use Disorder, Moderate | F10.20 | 6C40.1 |
| Autism Spectrum Disorder, Level 2 | F84.0 | 6A02.1 |
| Schizophrenia, Continuous | F20.9 | 6A20.0 |
| Prolonged Grief Disorder (NEW in TR) | F43.81 | 6B42 |
Documentation Note: For billing and insurance purposes in the US, clinicians must use ICD-10-CM codes. DSM-5-TR appendix provides complete crosswalk. When ICD-11 is adopted in US, codes will change but DSM-5-TR diagnoses remain valid.
Critical Perspectives & Limitations
While the DSM-5-TR is the clinical standard, scholarly critique informs its ongoing evolution. Understanding limitations strengthens clinical judgment.
Categorical vs. Dimensional Debate
Critique: Mental disorders don't have clear boundaries. Why does 5 of 9 depression symptoms = disorder, but 4 of 9 = normal? Arbitrary thresholds create false dichotomies.
DSM Response: DSM-5 added dimensional severity ratings and cross-cutting symptom measures. Future revisions may adopt more dimensional approaches while maintaining clinical utility of categorical diagnosis for treatment decisions.
Research Alternative: RDoC (Research Domain Criteria) framework classifies by neurobiological dimensions rather than symptoms, better for research, less practical for clinical care.
Medicalization & Overdiagnosis
Critique: Expanding diagnostic criteria and removing exclusions (e.g., bereavement exclusion for depression) risks pathologizing normal human experiences. Pharmaceutical industry influence on diagnostic criteria development raises concerns about conflict of interest.
DSM Response: All DSM revisions require rigorous evidence review. Criteria B (functional impairment) guards against overdiagnosis. Cultural context and clinical judgment essential, diagnosis requires clinically significant distress/impairment, not just symptom presence.
Example: Normal grief can include 5+ depression symptoms but without persistent functional impairment typically resolves without diagnosis. Prolonged Grief Disorder diagnosis requires 12+ months of intense, impairing grief.
Validity & Reliability Concerns
Critique: DSM-5 field trials reported inter-rater reliability (κ) ranging from <0.20 to 0.79 across 23 tested diagnoses - 6 fell in the "questionable" range (0.20–0.39) and 3 were unacceptable (<0.20). [Regier et al., 2013, PMID 23111466]
DSM Response: The same field trials concluded most diagnoses had good to very good reliability (κ 0.40–0.79). Structured interviews (SCID-5) further improve consistency. Training and clinical experience remain essential for accurate application.
Context: Psychiatry lacks criterion-standard biomarkers. All psychiatric diagnosis relies on syndromal pattern recognition. Variability reflects genuine diagnostic complexity - most tested disorders achieved clinically acceptable reliability, and the picture is more positive than early media reports suggested.
Cultural Bias & Western-Centrism
Critique: DSM developed in Western psychiatric tradition; may not capture non-Western expressions of distress. Some cultural syndromes don't map cleanly to DSM categories. Risk of diagnostic imperialism, imposing Western categories globally.
DSM Response: DSM-5-TR substantially updated Culture-Related Diagnostic Features across disorder categories. Added Cultural Formulation Interview. Glossary retains 9 named Cultural Concepts of Distress (streamlined from 25 in DSM-IV-TR for clinical focus). Encourages culturally-informed diagnosis rather than universal application of Western categories.
Ongoing Work: APA's Committee on Psychiatric Diagnosis and Assessment continues addressing cultural considerations. ICD-11 (WHO) provides international perspective complementing DSM's North American focus.
Balanced Perspective
The DSM is an imperfect but necessary tool. It standardizes communication, guides treatment, enables insurance reimbursement, and advances research. Critiques drive improvements, DSM-5-TR incorporated many suggestions from DSM-5 critics. Clinicians should use DSM as a guide, not a cookbook, combining diagnostic criteria with clinical judgment, cultural competence, and individualized assessment. As stated in DSM-5-TR introduction: "Diagnosis is only the first step toward appropriate treatment; clinical management requires consideration of the individual's cultural background, life circumstances, and personal preferences."
Future of the DSM: DSM-6 and Beyond
The American Psychiatric Association has not announced a timeline for DSM-6, but several emerging trends will likely shape future revisions:
Biological Markers & Neuroscience
Future DSM revisions may incorporate biomarkers, neuroimaging findings, and genetic data alongside symptom-based criteria. The Research Domain Criteria (RDoC) framework, developed by NIMH, already classifies disorders by neuroscience dimensions rather than symptom clusters.
Example: Instead of diagnosing "Major Depression" solely by symptoms, future criteria might include serotonin transporter polymorphisms (5-HTTLPR), HPA axis dysregulation markers, or specific patterns in fMRI scans of reward circuitry.
Dimensional vs. Categorical Diagnosis
Moving from binary "yes/no" diagnoses to spectrum-based assessments that capture severity, functional impairment, and symptom heterogeneity.
- Severity Scales: Quantifying symptom intensity rather than threshold cutoffs
- Cross-Cutting Symptoms: Recognizing that anxiety, sleep, cognition appear across multiple disorders
- Longitudinal Trajectories: Tracking symptom evolution over time vs. snapshot diagnosis
Cultural & Contextual Factors
Greater emphasis on how culture, environment, and social determinants shape mental health presentation:
Cultural Idioms of Distress
Expanding cultural concepts beyond Western psychiatric models (e.g., "susto" in Latino cultures, "taijin kyofusho" in Japan)
Environmental Context
Incorporating socioeconomic status, trauma exposure, discrimination, and systemic barriers into diagnostic formulation
Digital Phenotyping & AI
Technology for continuous monitoring and pattern detection:
- Passive Data Collection: Sleep patterns, physical activity, social interactions via smartphones
- Machine Learning: Identifying diagnostic patterns in large datasets that humans can't detect
- Real-Time Assessment: Ecological momentary assessment replacing retrospective self-report
Challenges Ahead
Any DSM-6 revision must balance scientific advances with clinical utility. Biomarker-based diagnosis faces challenges: limited access to neuroimaging, cost barriers, and the reality that most clinicians diagnose based on interview and observation. The DSM must remain practical for frontline providers while incorporating emerging research.
HiBoop & DSM-5-TR Alignment
How HiBoop integrates current diagnostic standards into clinical workflow
DSM-5-TR Aligned Assessments
All HiBoop assessment tools map directly to DSM-5-TR criteria (PHQ-9 for depression, GAD-7 for anxiety, PCL-5 for PTSD). Automated scoring flags symptom clusters matching diagnostic thresholds.
Severity Tracking
Dimensional assessment approach consistent with DSM-5-TR severity specifiers. Track symptom changes over time rather than binary diagnoses.
Cultural Considerations
Assessment library includes culturally validated tools and accommodates diverse presentations aligned with DSM-5-TR cultural formulation guidance.
Evidence-Based Updates
As DSM criteria evolve, HiBoop assessment algorithms update to reflect latest diagnostic standards and clinical research.
Differential Diagnosis: Distinguishing Similar Disorders
Differential diagnosis, ruling out alternative explanations for symptoms, is central to accurate assessment. Many disorders share overlapping symptoms requiring systematic comparison.
Depression vs. Bipolar Disorder
Key Distinction: History of manic/hypomanic episode
Clinical Pitfall: 60% of patients with bipolar disorder initially present with depression. Requires careful lifetime history review. Family history of bipolar disorder increases suspicion.
Decision Rule: ANY history of manic episode (7+ days) or hypomanic episode (4+ days) = Bipolar, even if currently depressed
GAD vs. Depression (with worry)
Key Distinction: Content and pervasiveness of worry
GAD: Worry is excessive, uncontrollable, about multiple domains (work, health, finances, family). Worry is the primary complaint.
Depression: Worry typically limited to depressive themes (being worthless, burden to others, hopelessness about future).
PTSD vs. Adjustment Disorder
Key Distinction: Severity and type of stressor
PTSD: Requires Criterion A trauma (death, serious injury, sexual violence, actual or threatened). Includes re-experiencing, avoidance, negative cognitions, hyperarousal.
Adjustment: Stressor doesn't meet Criterion A. Response disproportionate but doesn't include full PTSD symptom clusters.
Schizophrenia vs. Substance-Induced Psychosis
Key Distinction: Temporal relationship to substance use
Substance-Induced: Psychotic symptoms emerge during/soon after intoxication or withdrawal. Resolve within days-weeks of abstinence.
Schizophrenia: Symptoms persist beyond substance clearance. Often preceded substance use or persisted during extended abstinence periods.
Autism vs. Social Anxiety Disorder
Key Distinction: Understanding vs. fear of social situations
Autism: Social communication deficits, difficulty reading social cues, understanding nonverbal communication, maintaining reciprocal conversation. Not anxious but genuinely doesn't understand social "rules."
Social Anxiety: Understands social expectations but fears negative evaluation. Avoidance driven by anxiety, not social comprehension deficit.
ADHD vs. Bipolar Disorder (pediatric)
Key Distinction: Episodic vs. persistent symptoms
ADHD: Chronic, stable hyperactivity/impulsivity from early childhood. No distinct mood episodes.
Bipolar: Episodic changes in mood/energy distinct from baseline. Irritability comes in waves, not constant. Sleep changes and grandiosity distinguish from ADHD.
Systematic Approach: DSM-5-TR provides "Differential Diagnosis" sections for each disorder. Always review these systematically. Consider: (1) Medical conditions, (2) Substance-induced, (3) Other primary psychiatric disorders, (4) Normal variation/adjustment reactions. When uncertain, longitudinal observation often clarifies diagnosis better than cross-sectional assessment.
Scholarly References & Further Reading
All peer-reviewed references include PubMed IDs (PMID) for source verification.
Institutional & Guideline Sources
American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Arlington, VA: American Psychiatric Publishing. Official APA DSM Site
World Health Organization. (2022). ICD-11: International Classification of Diseases, 11th Revision. Geneva: WHO. ICD-11 Browser
National Institute of Mental Health (NIMH). (2024). Research Domain Criteria (RDoC). Bethesda, MD: NIMH. NIMH Research Domain Criteria (RDoC)
National Institute for Health and Care Excellence (NICE). (2023). Mental Health: Clinical Practice Guidelines. London: NICE. NICE Mental Health Guidelines
SAMHSA. (2023). Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health. Rockville, MD: SAMHSA. NSDUH 2022 Report
Peer-Reviewed Research
First, M.B., Williams, J.B.W., Karg, R.S., & Spitzer, R.L. (2016). Structured Clinical Interview for DSM-5 Disorders, Clinician Version (SCID-5-CV). Arlington, VA: American Psychiatric Association.
Patel, S.R., Wisner, K., & Bailey, R.K. (2023). What's New in DSM-5-TR: Implications for Clinical Practice and Research. American Journal of Psychiatry, 180(1), 10-12.
Shear, M.K., Reynolds, C.F., Simon, N.M., et al. (2016). Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial. JAMA Psychiatry, 73(7), 685-694. PMID 27276373
Lewis-Fernández, R., Aggarwal, N.K., Hinton, L., et al. (2016). DSM-5 Handbook on the Cultural Formulation Interview. Arlington, VA: American Psychiatric Publishing.
Insel, T., Cuthbert, B., Garvey, M., et al. (2010). Research Domain Criteria (RDoC): Toward a New Classification Framework for Research on Mental Disorders. American Journal of Psychiatry, 167(7), 748-751. PMID 20595427
Kotov, R., Krueger, R.F., Watson, D., et al. (2017). The Hierarchical Taxonomy of Psychopathology (HiTOP): A Dimensional Alternative to Traditional Nosologies. Journal of Abnormal Psychology, 126(4), 454–477. PMID 28333488
Kotov, R., Krueger, R.F., Watson, D., et al. (2017). The Hierarchical Taxonomy of Psychopathology (HiTOP): A Dimensional Alternative to Traditional Nosologies. Journal of Abnormal Psychology, 126(4), 454-477. PMID 28333488
Regier, D.A., Narrow, W.E., Clarke, D.E., et al. (2013). DSM-5 Field Trials in the United States and Canada, Part II: Test-Retest Reliability of Selected Categorical Diagnoses. American Journal of Psychiatry, 170(1), 59-70. PMID 23280036
Wakefield, J.C. (2016). Diagnostic Issues and Controversies in DSM-5: Return of the False Positives Problem. Annual Review of Clinical Psychology, 12, 105-132. PMID 26651017
Kessler, R.C., Chiu, W.T., Demler, O., & Walters, E.E. (2005). Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617-627. PMID 15939837
Regier, D.A., Farmer, M.E., Rae, D.S., et al. (1990). Comorbidity of Mental Disorders with Alcohol and Other Drug Abuse: Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264(19), 2511-2518. PMID 2232018
Hudson, J.I., Hiripi, E., Pope, H.G., & Kessler, R.C. (2007). The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61(3), 348-358. PMID 16815322
Brady, K.T., & Sinha, R. (2005). Co-occurring Mental and Substance Use Disorders: The Neurobiological Effects of Chronic Stress. American Journal of Psychiatry, 162(8), 1483-1493. PMID 16055769
Kirmayer, L.J., & Sartorius, N. (2007). Cultural Models and Somatic Syndromes. Psychosomatic Medicine, 69(9), 832-840. PMID 18040104
Hinton, D.E., & Lewis-Fernández, R. (2011). The Cross-Cultural Validity of Posttraumatic Stress Disorder: Implications for DSM-5. Depression and Anxiety, 28(9), 783-801. PMID 21739467
DuPaul, G.J., Gormley, M.J., & Laracy, S.D. (2013). Comorbidity of LD and ADHD: Implications of DSM-5 for Assessment and Treatment. Journal of Learning Disabilities, 46(1), 43-51. PMID 23144063
Leitner, Y. (2014). The Co-Occurrence of Autism and Attention Deficit Hyperactivity Disorder in Children: What Do We Know? Frontiers in Human Neuroscience, 8, 268. PMID 24808851
Narrow, W.E., Clarke, D.E., Kuramoto, S.J., et al. (2013). DSM-5 Field Trials in the United States and Canada, Part III: Development and Reliability Testing of a Cross-Cutting Symptom Assessment for DSM-5. American Journal of Psychiatry, 170(1), 71-82. PMID 23280035
Kroenke, K., Spitzer, R.L., & Williams, J.B. (2001). The PHQ-9: Validity of a Brief Depression Severity Measure. Journal of General Internal Medicine, 16(9), 606-613. PMID 11556941
Need Expert Clinical Guidance?
HiQō provides AI-powered clinical decision support trained on DSM-5-TR diagnostic criteria, differential diagnosis considerations, and evidence-based assessment protocols. Ask about specific diagnostic questions, comorbidity patterns, or cultural formulation guidance.
Ask HiQō About DSM-5-TR CriteriaAdditional Resources
• Psychiatry Online: Full-text DSM-5-TR (subscription required) at psychiatryonline.org
• NIMH Statistics: Prevalence data at nimh.nih.gov/health/statistics
• APA Practice Guidelines: Evidence-based treatment recommendations for specific disorders
• Cochrane Mental Health Reviews: Systematic reviews of treatment efficacy
• UpToDate Psychiatry: Clinical summaries with DSM-5-TR integration
On This Page
By The Numbers
Official DSM Sources
Ask HiQō
AI-powered clinical assistant
Get instant answers about DSM criteria, differential diagnosis, and clinical decision support
Chat with HiQōHiBoop Resources
This resource provides educational information about the DSM-5-TR. It is not a substitute for professional clinical training or diagnosis.